Organon & Co

NYSE : OGN
USA·Healthcare·Drug Manufacturers·Ordinary Shares
$13.76
+0.00 (+0.00%)Oct 16 close
Market Cap
$3.58B
Enterprise Value
$11.00B
P/E (TTM)
17.87
P/B
3.59
Net Cash / (Debt)
−$7.42B
52-Week Range
$5.70 — $14
5-Year Range
$5.70 — $39
Avg Volume (3M)
2.65M
Transcripts

Organon & Co at Piper Sandler Healthcare Conference Transcript

2022-11-29Conference Presentations

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.

Upgrade to Pro